Trial Review

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12620001269921
Ethics application status
Approved
Date submitted
10/11/2020
Date registered
25/11/2020
Date last updated
25/11/2020
Date data sharing statement initially provided
25/11/2020
Type of registration
Prospectively registered

Titles & IDs
Public title
The Loddon Mallee Healthcare Worker COVID-19 Study
Scientific title
The Loddon Mallee Healthcare Worker COVID-19 Study: A longitudinal cohort study exploring the impacts of COVID-19 on the health and wellbeing of the rural and regional health care workforce.
Secondary ID [1] 302750 0
None
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
COVID-19 319694 0
Anxiety 319695 0
Depressive symptoms 319696 0
Resilience 319799 0
Condition category
Condition code
Public Health 317622 317622 0 0
Epidemiology
Mental Health 317623 317623 0 0
Depression
Mental Health 317624 317624 0 0
Anxiety
Mental Health 317625 317625 0 0
Other mental health disorders

Intervention/exposure
Study type
Observational
Patient registry
False
Target follow-up duration
Target follow-up type
Description of intervention(s) / exposure
This study will use a longitudinal study design to explore and describe the health and wellbeing impacts of the COVID-19 pandemic among the rural/regional healthcare Workers. Online questionnaires will be self-completed by participants every 6 months for the next three years with shorter questionnaires at 3, 9 and 15 months. The assessments include:
Patient sociodemographic questions
COVID-19 infection history
COVID-19 infection control training
Mortality
Cause of death
Morbidity
Height & weight
Disease-specific symptoms
Medication use
Resting pulse
Blood pressure
Hearing
Vision
Screening
Delayed or postponed screening
Contraception use
Hormone replacement use
Reproductive history
Personal welling index (PWI-A)
Generalised Anxiety Disorder -7 (GAD-7)
Fear of COVID-19 Scale
Impact of events scale-6 (IES-6)
Patient Health Questionnaire (PHQ-9)
Perceived Stress Scale (PSS)
Suicidal Behaviors Questionnaire-Revised (SBQ-R)
Brief Resilience Scale (BRS)
Short Form-12 (SF-12)
The Adult State (Snyder) Hope Scale
General Self Efficacy Scale
Brief COPE Scale
Penn State Worry Questionnaire (PSWQ)
Life Orientation Test-Revised (LOT-R)
Self-compassion scale: short form (SCS-SF)
Self-control and self-management behaviour scale
Childhood trauma Questionnaire - Short Form (CTQ-SF)
Mindfulness attention awareness scale (MAAS)
Big 5 Inventory-Short form
MOS (6-item cognition questions)
Duke Social Support Index
UCLA Loneliness Scale Version 3
Recent life events questionnaire (12-items)
Self-control and self-management behaviour scale
International Physical Activity Questionnaire short form
AUDIT Alcohol Screening Tool
Smoking questionnaire
Pittsburgh Sleep Quality Index
Short diet quality questions (14-items)
General Functioning Index of the McMaster Family Assessment Device (FAD)
Health services use
Job Stress Scale
Satisfaction with Work Scale
Work engagement: Utrecht Work Engagement Scale
Copernhagen Burnout Inventory
Job-stress-related presenteeism
Occupational self-efficacy scale (OSE)
The Multilevel Safety Climate (MSC) Scale
Psychologically safe workplace questionnaire
Neighborhood cohesion
Intervention code [1] 319035 0
Not applicable
Comparator / control treatment
No control group
Control group
Uncontrolled

Outcomes
Primary outcome [1] 325664 0
All cause mortality will be determined by data linkage to the National Death Index
Timepoint [1] 325664 0
All cause mortality will determined at the end of years 1, 2, and 3 through record linkage.
Primary outcome [2] 325665 0
Morbidity will be determined by data linkage to medical records and through follow-up questionnaires at the end of years 1, 2 and 3.
Timepoint [2] 325665 0
Morbidity will determined at the end of years 1, 2, and 3 through record linkage and follow-up questionnaires.
Primary outcome [3] 325666 0
Anxiety will be measured using the Generalised Anxiety Disorder Scale (GAD-7)
Timepoint [3] 325666 0
Anxiety will determined every 6 months post-enrolment for a period of three years using follow-up questionnaires.
Secondary outcome [1] 388726 0
Physical functioning will determined using the Short Form-12 using baseline and follow-up questionnaires.
Timepoint [1] 388726 0
Physical functioning will determined every 6 months post-enrolment for a period of three years using follow-up questionnaires.
Secondary outcome [2] 388727 0
Quality of Life will determined using the Short Form-12 using baseline and follow-up questionnaires.
Timepoint [2] 388727 0
Quality of Life will determined every 6 months post-enrolment for a period of three years using follow-up questionnaires.
Secondary outcome [3] 388728 0
Health service utilisation will be determined using data-linkage to medical records and through online questionnaires.
Timepoint [3] 388728 0
Health service utilisation will be determined using data-linkage to medical records and through online questionnaires every 6-months for a period of three years.

Eligibility
Key inclusion criteria
• Age 18 or over
• Currently working within a Loddon Mallee health service
• Ability to provide informed consent
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
Yes
Key exclusion criteria
• Inability to use electronic devices (required to complete the questionnaire)
• Non-English-speaking people

Study design
Purpose
Psychosocial
Duration
Longitudinal
Selection
Defined population
Timing
Prospective
Statistical methods / analysis
It is expected that a sample of 4000 healthcare workers will be recruited at baseline and that 20% of these participants will be lost to follow-up, resulting in approximately 3200 participants available at the end of the 3-year follow-up. This sample size still provides more than 80% power to detect the important associations examined by this study.

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
27/11/2020
Actual
Date of last participant enrolment
Anticipated
31/08/2023
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
4000
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
VIC

Funding & Sponsors
Funding source category [1] 307171 0
Government body
Name [1] 307171 0
Victorian Department of Health and Human Services
Country [1] 307171 0
Australia
Primary sponsor type
Hospital
Name
Bendigo Health
Address
100 Barnard Street Bendigo, 3550, Victoria, Australia
Country
Australia
Secondary sponsor category [1] 307767 0
University
Name [1] 307767 0
La Trobe University Rural Health School
Address [1] 307767 0
PO Box 199, Bendigo Victoria 3552
Country [1] 307767 0
Australia

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 307285 0
Bendigo Health Human Research Ethics Committee
Ethics committee address [1] 307285 0
Ethics committee country [1] 307285 0
Australia
Date submitted for ethics approval [1] 307285 0
12/10/2020
Approval date [1] 307285 0
11/11/2020
Ethics approval number [1] 307285 0
LNR/20/BH/68671

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 106686 0
A/Prof Mark McEvoy
Address 106686 0
La Trobe University Rural Health School
PO Box 199, Bendigo Victoria 3552
Country 106686 0
Australia
Phone 106686 0
+61401570809
Fax 106686 0
Email 106686 0
[email protected]
Contact person for public queries
Name 106687 0
Carol Parker
Address 106687 0
Bendigo Health
100 Barnard Street Bendigo, Victoria 3550
Country 106687 0
Australia
Phone 106687 0
+61 0354546000
Fax 106687 0
Email 106687 0
[email protected]
Contact person for scientific queries
Name 106688 0
Mark McEvoy
Address 106688 0
La Trobe University Rural Health School
PO Box 199, Bendigo Victoria 3552
Country 106688 0
Australia
Phone 106688 0
+61401570809
Fax 106688 0
Email 106688 0
[email protected]

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
No/undecided IPD sharing reason/comment


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.